DNB CTVS question- December 2015

DECEMBER 2015

PAPER 1
1. Anatomy of Mitral valve in reference to: a)Types of chordae.b)Fibrous Trigones and their anatomical relations.c)Carpentier’s classification of Mitral Regurgitation.d)Mitral Leaflets.3+3+2+2
2. Newer Anticoagulant Agents:a)Enumerate them.b)Mechanism of Action. c)Disadvantages. d)Advantages over Warfarin. e)Antidote.2×5
3. a)Intention to Treat Analysis. b)Level of Evidence. c)Hazard Ratio. d)Confidence Interval.2.5×4
4. Cardiopulmonary Bypass:a)Alfa stat versus pHstat strategy.b)Recent advances.c)Pulsatile versus Non pulsatile flow.4+3+3
5. Coronary Sinus: a)Anatomy and tributaries. b)Therapeutic interventions through Coronary sinus: i.Surgical ii.Percutaneous 4+3+3
6. a)Ejection Fraction and its reliability b)LVEDP( L.V.End Diastolic Pressure) c)Qp:Qs Ratio and its calculation d)Pulmonary Capillary Wedge pressure –Relevance and Fallability2+2+3+3.
7. a)Interventricular  dependence.b)Action potential of Cardiac myocyte.c)Embryology of atrial septum.3+3+4
8. a)Lymphatic drainage of lungs.b)Embryological basis of Pulmonary Sequestration 5+5
9. a)Arterial supply of oesophagus.b)Drainage of lymphatic duct.5+5
10. Pathophysiological basis and aetiology of hoarseness of voice: a)Cardiac causes b)Pulmonary causesc)Vascular causes4+3+3

PAPER –II  DECEMBER 2015

1.Fontan operation with specific reference to:a)Indicationsb)Modifications & typesc)Late outcomes 3+3+4
2.Off Pump Coronary Artery Bypass Surgery (OPCAB) :a)Provide evidence base for its use.b)Relative & absolute contraindications.c)Mechanical and Pharmacological adjuncts used in OPCAB. 4+2+(2+2)
3.Heart failure:a)Types and aetiology b)Pharmacotherapy c)Mechanical devices as Bridge to recovery 4+3+3
4.AtrialFibrillation:a)Patho-physiological basis.b)Cox-Maze 3 procedure.c)Energy sources.d)Minimally Invasive techniques. 3+3+2+2
5.How to differentiate:a)Restrictive Versus Constrictive Physiology. b)Mild to moderate aortic stenosis versus severe low gradient AS. c)Flow limiting Versus non flow limiting  coronary stenosis. d)Early LV Dysfunction from normal L V in mitral registration. 3+3+2+2
6.Cardiac Tumors:a)Types and Prevalence b)Presentation in infancy c)Management of the commonest tumour in infancy  (2+1)+3+4
7.a)Aortic Valve Conservation.b)Repair Versus replacement in ischaemic mitral regurgitation.c)Indications of emergent surgery in infective endocarditis.4+3+3
8.CononaryArtery Disease:a)Class I  indications for PCI (Percutaneous Coronary Intervention)b)PCI versus CABG in Diabetics –current evidence c)Why is LIMA  to  LAD  considered  a  gold standard  and  reasons  for its good results & high patency?3+4+3
9.Transposition of great arteries:a)Morphology,b)Embryological basisandc)Management beyond 3 months.3+2+5
10.a)Indications of heart transplantation.b)Techniques described for heart transplantation.c)Immuno suppression therapy following heart transplantation.2+4+4

PAPER –III: DECEMBER 2015
1. Aortic Dissection:   a)Classification.   b)Aetiology.       c)Which single imaging technique would you choose & why?            d)Valve conservation surgery for acute Type-I dissection.2+2+2+4
2. Lung Volume Reduction Surgery:    a)Indications.          b)Patho-physiological basis.      c)Contraindications.           d)Surgical approaches.2+3+2+3
3. a)Issues with percutaneous,aortic valve replacement.         b)Recent advances in percutaneous mitral valve repair.        c)Domiciliary care of prosthetic heart valves.3+4+3
4. Pectus Excavatum:    a)Physiological consequences.     b)Aetiology  c)Surgical techniques.3+2+5
5. a)Assessment of myocardial viability.        b)Assessment of reversibility of pulmonary arterial hypertension.                c)Diagnosis of spontaneous oesophapeal rupture.4+3+3
6. a)Recent advances in Robotic technologies.     b)Indications of VATS in thoracic surgery. c)Neurological complications following minimally invasive mitral valve surgery.4+3+3
7. Chylothorax:    a)Aetiology.       b)Biochemical diagnosis of chyle.  c)Indications of surgeryd)Medical management & surgical options/techniques 3+2+2+3
8. a)PARTNER Trial b)SYNTAX Trial c)FREEDOM Trial d)COURAGE Trial 2.5×4
9. Empyema thoracis:    a)Classification     b)Etiopathogenesis    c)Light’s Criteria       d)Recent advances in managementof Empyema thoracis.2+3+3+2
10. Deep vein thrombosis:     a)Etiology & diagnosis        b)Complications c)Management        d)Enumerate percutaneous  interventions 4+2+2+2

Author: what2talk

Myself, Dr. Sibashankar Kar, doing my Cardiothoracic Surgery in Sir Ganga Ram Hospital. The purpose I have made this website is to discuss on the topics of cardiology and cardiac surgery as a whole with their complexities.

Leave a Reply